Pentoxifylline: Clinical Trials

69 trials of Pentoxifylline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 14 unknown, 7 terminated, 6 recruiting. 69 Phase 2, 14 Phase 3, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 269Completed 39, Unknown 14, Terminated 7, Recruiting 6, Not yet recruiting 2, Withdrawn 1
Phase 314Completed 8, Unknown 5, Not yet recruiting 1
Phase 110Completed 6, Unknown 2, Not yet recruiting 1, Withdrawn 1

Follow Pentoxifylline: new trials by email Literature Review of Pentoxifylline trials Research Report on Pentoxifylline

Trials (filtered) newest first · largest first

All 69 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Pentoxifylline, Placebo, α-Tocopherol - Non-Small Cell Lung Cancer, Radiation Induced Lung Injury (RILI)
Phase 2RecruitingUniversity Health Network, Toronto1502026-06-152026-08-06
Pentoxifylline in Patients With Ulcerative Colitis
Mesalamine, Pentoxifylline - Inflammatory Bowel Diseases
Phase 2RecruitingIhab Elsayed Hassan602026-01-202026-04-15
Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Pentoxifylline 400mg plus chemotherapy - Doxorubicin Induced Cardiotoxicity, Breast Cancer
Phase 2CompletedTanta University462025-09-012026-09-30
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Pravastatin (drug), Pentoxifylline, ketoprofen - Fibrosis Syndrome, Lymphedema
Phase 2RecruitingM.D. Anderson Cancer Center2502025-08-082026-07-24
Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
Methotrexate, Pentoxifylline - Rheumatoid Arthritis
Phase 2RecruitingTanta University502025-06-022026-10-05
Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice
Pentoxifylline - Hepatobiliary Disorders
Phase 2CompletedTanta University452025-04-302026-09-30
Pentoxifylline for Vascular Calcification in Kidney Disease
Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification
Phase 1 / Phase 2Not yet recruitingMansoura University802025-04-152025-04-01
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Pravastatin, Pentoxifylline, Tocopherol - Lymphedema, Fibrosis
Phase 2RecruitingM.D. Anderson Cancer Center2952025-02-132026-09-11
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis
Phase 1 / Phase 2CompletedZiauddin University302024-08-122025-05-02
Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke
Pentoxifylline - Cognitive Impairment
Phase 1 / Phase 2UnknownThe First Hospital of Hebei Medical University2002024-04-102024-04-03
Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers
Topical Pentoxifylline Gel (Vehicle +PTX), Topical Placebo Gel (Vehicle) - Behcet Syndrome, Behcet Disease
Phase 2UnknownSilk Road Therapies, Inc.602024-02-012023-08-03
Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer
Pentoxifylline 400mg plus chemotherapy, Chemotherapy - Breast Cancer Female, Breast Cancer Patients
Phase 2CompletedMansoura University1002023-12-252025-07-28
Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"
Pentoxifylline Oral Tablet, Placebo - Breast Cancer Female
Phase 2UnknownMansoura University702023-12-152024-03-15
The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery
Pentoxifylline, paracetamol +ketorolac - Post-Surgical Complication, Breast Cancer Surgery
Phase 2CompletedMansoura University922023-10-302025-06-26
Role of Pentoxifylline and Celecoxib in Parkinsonism
carbidopa-levodopa, Pentoxifylline 400 MG, Celecoxib 200mg - Parkinson Disease
Phase 2CompletedMostafa Bahaa802023-08-072025-08-12
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib - Diabetic Kidney Disease
Phase 2TerminatedIain Bressendorff12023-08-012024-09-25
Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes
tadalafil, Sildenafil, pentoxifylline - IVF
Phase 2 / Phase 3UnknownBeni-Suef University2002023-07-302023-08-03
Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men
Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet - Sexually Transmitted Diseases
Phase 2 / Phase 3Not yet recruitingTanta University1002023-06-202023-06-12
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
Ibudilast, Pentoxifylline, Placebo - Long COVID, Post COVID Condition
Phase 2 / Phase 3CompletedUniversity Health Network, Toronto4602023-05-312026-02-23
Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
Pentoxifylline 400 MG - Inflammatory Bowel Diseases
Phase 2CompletedTanta University602023-02-022026-09-17

Showing 20 of 69. Sign in to see all of them.

Conditions studied

Breast Neoplasms (7)  ·  Fibrosis (6)  ·  Cardiovascular Diseases (3)  ·  Inflammation (3)  ·  Inflammatory Bowel Diseases (3)  ·  Lymphedema (3)  ·  Atherosclerosis (2)  ·  Depressive Disorder, Major (2)  ·  Diabetic Nephropathies (2)  ·  Fatty Liver (2)  ·  Head and Neck Neoplasms (2)  ·  Kidney Failure, Chronic (2)  ·  Leishmaniasis (2)  ·  Leishmaniasis, Cutaneous (2)  ·  Muscular Dystrophy, Duchenne (2)

Sponsors

Tanta University (7)  ·  Ain Shams University (4)  ·  Mansoura University (4)  ·  University Health Network, Toronto (4)  ·  Indiana University (3)  ·  M.D. Anderson Cancer Center (3)  ·  Cooperative International Neuromuscular Research Group (2)  ·  Hawler Medical University (2)  ·  Mostafa Bahaa (2)  ·  Royal Marsden NHS Foundation Trust (2)  ·  Sadat City University (2)  ·  Shaare Zedek Medical Center (2)  ·  Taipei Medical University Hospital (2)  ·  University of Brasilia (2)  ·  Baylor College of Medicine (1)

Countries

United States (21)  ·  Egypt (19)  ·  Canada (5)  ·  Israel (4)  ·  Brazil (3)  ·  Iran (2)  ·  Iraq (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  China (1)  ·  Colombia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Cathy Hammerman, MD (2)  ·  Diana Escolar, MD (2)  ·  Samir K. Gupta, MD, MS (2)  ·  Talar A Merzamohammad, Pharm. D (2)  ·  Wilfred Levin, MD (2)  ·  Alexandra Taylor (1)  ·  Amin Banihashemi (1)  ·  Andew J Sulich, MD (1)  ·  Angela M Cheung, MD,PhD (1)  ·  Arthur J McCullough, MD (1)  ·  Asmaa Saeed, Bachelor (1)  ·  Atef Taha, M.D (1)  ·  Chad Tang (1)  ·  Claudia O Zein, MD, MSc (1)  ·  Claudia O. Zein, MD, MSc (1)

Results publications

PMID 11675328, PMID 15542159, PMID 16155013, PMID 16322159, PMID 17366834, PMID 18358930, PMID 21220611, PMID 21677329, PMID 21748765, PMID 21846410, PMID 21943236, PMID 22037714, PMID 22074157, PMID 22086414, PMID 22265847, PMID 22323480, PMID 23140366, PMID 23244073, PMID 23593327, PMID 25393877, PMID 28379954, PMID 28390753, PMID 31472446, PMID 31748905, PMID 31811953, PMID 33008091, PMID 34007848, PMID 35084335, PMID 35093409, PMID 35340032, PMID 35410255, PMID 36341700, PMID 36552855, PMID 37011138, PMID 38817362, PMID 39192162, PMID 39340691, PMID 39421449, PMID 40253769, PMID 40393653, PMID 40739381, PMID 40741002, PMID 41164763, PMID 8618179

NIH funding

R01HL095149 (2), 2008 (1), R24MH080827 (1), U01AA021893 (1)